Francesca Maremonti

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 5

Top Topics

Diabetic Nephropathy

Top Venues

Cell death and differentiation

Science advances

Cell death & disease

Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme

This page only lists publications with an associated author ORCID identifier.

Publications

Francesca Maremonti, Wulf Tonnus, Shubhangi Gavali, Stefan Bornstein, Ajay Shah, Mauro Giacca, Andreas Linkermann
Ferroptosis-based advanced therapies as treatment approaches for metabolic and cardiovascular diseases. Cell death and differentiation 31 (9) (2024)
Francesca Maremonti, Wulf Tonnus, Shubhangi Gavali, Stefan Bornstein, Ajay Shah, Mauro Giacca, Andreas Linkermann
Ferroptosis-based advanced therapies as treatment approaches for metabolic and cardiovascular diseases. Cell death and differentiation (2024)
Anne von Mässenhausen, Nadia Zamora Gonzalez, Francesca Maremonti, Alexia Belavgeni, Wulf Tonnus, Claudia Meyer, Kristina Beer, Monica T Hannani, Arthur Lau, Mirko Peitzsch, Paul Hoppenz, Sophie Locke, Triantafyllos Chavakis, Rafael Kramann, Daniel A Muruve, Christian Hugo, Stefan R Bornstein, Andreas Linkermann
Dexamethasone sensitizes to ferroptosis by glucocorticoid receptor-induced dipeptidase-1 expression and glutathione depletion. Science advances 8 (5) (2022)
Francesca Maremonti, Sophie Locke, Wulf Tonnus, Kristina Beer, Anne Brucker, Nadia Zamora Gonzalez, Marcus Latk, Alexia Belavgeni, Paul Hoppenz, Christian Hugo, Andreas Linkermann
COVID-19 and Diabetic Nephropathy. Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme 54 (8) (2022)
Wulf Tonnus, Sophie Locke, Claudia Meyer, Francesca Maremonti, Lena Eggert, Anne von Mässenhausen, Stefan R Bornstein, Douglas R Green, Andreas Linkermann
Rubicon-deficiency sensitizes mice to mixed lineage kinase domain-like (MLKL)-mediated kidney ischemia-reperfusion injury. Cell death & disease 13 (3) (2022)